why choose us

First received: May 22, 2023

Clinical Trial: A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease

Brief Summary: The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD).The study will last about 113 weeks.

Read more